Document Page: First | Prev | Next | All | Image | This Release | Search

File: 970107_sep96_decls51_0004.txt
Page: 0004
Total Pages: 5

Subject: ADMINISTRATION OF ANTHRAX VACCINE                               

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: BOTULINUM VACCINATION PROGRAM                                                                   

Document Number:     190001

Folder Seq  #:     190000







                                ADMINISTRATION Of ANTM= VACCINZ

              PURPOSZ:    To   provide the necessary information for the safe
              administration   of the anthrax vaccine.

              BACKGROUND: An   alum-precipitated, inactivated, anthrax.vaccine has
              been approved   and licensed for human use by the Food and Drug
              Administration since 1972.       It has been shown to be safe and
              effective in protecting occupationally exposed individuals.

              STORAGZ: The anthrax vaccine should be kept refrigerated or on wet
              ice. Freezing or excess heat will inactivate the anthrax vaccine.

              SCHEDULE:- Two doses of anthrax vaccine should be given two weeks
              apart. A third dose of anthrax vaccine should be given two or more
              weeks after the second as additional anthrax vaccine becomes
              available.


              SIDZ ZFFZCTS:     Up to 6% of recipients will experience mild
              discomfort (tenderness, redness, swelling, or itching) at the
              inoculation site for up to 72 hours. Less than 1% will have more
              severe local reaction potentially limiting the use of the arm for
              I to'2 days.   Mild systemic reactions (muscle aches, fatigue, or
              fever) are uncommon and severe systemic reaction are rare. A few
              vaccinees will develop small, firm, painless nodules at the
              injection site which will persist for several weeks.

              ADt4lNISTRATION: The anthrax vaccine should be
            -given as follows:
                   1.   Shake the vaccine bottle immediately
              before use.      Even after thorough shaking
              anthrax vaccine  has a milky texture.
                   2.    Clean the rubber stopper with an
              alcohol  pad.
                   3. Use the alcohol pad to clean an area
              of skin on the back side of the upper arm (see
g).
                   4.   Draw up 0.5 cc of vaccine      into the
              syringe.                                                      muscle
                   5.    Using a     25  gauge,    5/811  needle,        subcutan
              administer the vaccine subcutaneously     at a 45            tissue
              degree angle into a pinch of skin on     backside             skin
              of the upper arm (see drawing).       Do not give
              this vaccine intramuscularly.
                   6,   Use separate arms when administering
              anthrax and botulinum vaccine simultaneously.
                   7.   Warn the patient to expect a burning
              sensation at the vaccine site approximately 30
              seconds after'vaccination lasting 1-2 minutes.




                                                                          SUBCUTANEOUS

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 5 f:/Week-36/BX003201/BOTULINUM VACCINATION PROGRAM/administration of anthrax vaccine:01029715474052
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = BOTULINUM VACCINATION PROGRAM
Folder Seq # = 190000
Subject = ADMINISTRATION OF ANTHRAX VACCINE
Document Seq # = 190001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997